BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2519889)

  • 21. Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.
    Ito S; Camussi G; Tetta C; Milgrom F; Andres G
    Lab Invest; 1984 Aug; 51(2):148-61. PubMed ID: 6379289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eicosanoids and platelet activating factor mechanisms in organ rejection.
    Foegh ML
    Transplant Proc; 1988 Dec; 20(6):1260-3. PubMed ID: 3059615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-activating factor in septic shock.
    Koltai M; Hosford D; Braquet PG
    New Horiz; 1993 Feb; 1(1):87-95. PubMed ID: 7922397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autocrine/paracrine involvement of platelet-activating factor and transforming growth factor-beta in the induction of phosphatidylserine recognition by murine macrophages.
    Rose DM; Fadok VA; Riches DW; Clay KL; Henson PM
    J Immunol; 1995 Dec; 155(12):5819-25. PubMed ID: 7499871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor: a putative neuromodulator and mediator in the pathophysiology of brain injury.
    Yue TL; Feuerstein GZ
    Crit Rev Neurobiol; 1994; 8(1-2):11-24. PubMed ID: 7907280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet activating factor and its metabolite promote sleep in rabbits.
    Kushikata T; Fang J; Krueger JM
    Neurosci Lett; 2006 Feb; 394(3):233-8. PubMed ID: 16263215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils.
    van der Bruggen T; Kok PT; Raaijmakers JA; Lammers JW; Koenderman L
    J Immunol; 1994 Sep; 153(6):2729-35. PubMed ID: 8077677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of platelet activating factor in hemodialysis.
    Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
    Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in nitric oxide production in various forms of circulatory shock.
    Szabó C
    New Horiz; 1995 Feb; 3(1):2-32. PubMed ID: 7535648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cytokines and platelet-activating factor in microvascular immune injury.
    Braquet P; Hosford D; Braquet M; Bourgain R; Bussolino F
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):88-100. PubMed ID: 2651321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a case for PAF antagonists in the treatment of ischemic states?
    Braquet P; Paubert-Braquet M; Koltai M; Bourgain R; Bussolino F; Hosford D
    Trends Pharmacol Sci; 1989 Jan; 10(1):23-30. PubMed ID: 2688213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of PAF in atherogenesis. Brief review.
    Koltai M; Braquet PG
    Agents Actions Suppl; 1992; 37():333-9. PubMed ID: 1632308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathobiology of platelet-activating factors.
    McManus LM
    Pathol Immunopathol Res; 1986; 5(2):104-17. PubMed ID: 3543915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 'catastrophic' fall!
    Khan F; Applewaite R; Abdullah A
    Clin Med (Lond); 2023 Nov; 23(Suppl 6):25-26. PubMed ID: 38182209
    [No Abstract]   [Full Text] [Related]  

  • 36. Inflammation in Metabolic and Cardiovascular Disorders-Role of Oxidative Stress.
    Sun Y; Rawish E; Nording HM; Langer HF
    Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells.
    Zhang F; Liu L; Zhang H; Liu ZL
    Drug Des Devel Ther; 2020; 14():4205-4214. PubMed ID: 33116408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis.
    Zhang H; Yang Y; Takeda A; Yoshimura T; Oshima Y; Sonoda KH; Ishibashi T
    PLoS One; 2013; 8(6):e68173. PubMed ID: 23826375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation and cardiac surgery: a novel target for improving outcomes.
    Stahl GL; Shernan SK; Smith PK; Levy JH
    Anesth Analg; 2012 Oct; 115(4):759-71. PubMed ID: 22798530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent.
    Borthakur A; Bhattacharyya S; Alrefai WA; Tobacman JK; Ramaswamy K; Dudeja PK
    Inflamm Bowel Dis; 2010 Apr; 16(4):593-603. PubMed ID: 19714753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.